CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 36 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $579,000 | -63.6% | 628,000 | -63.7% | 0.00% | – |
| Q3 2020 | $1,590,000 | +2.2% | 1,728,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,556,000 | -56.6% | 1,728,000 | -57.1% | 0.00% | – |
| Q1 2020 | $3,583,000 | +2.3% | 4,028,000 | 0.0% | 0.00% | – |
| Q4 2019 | $3,501,000 | +0.1% | 4,028,000 | 0.0% | 0.00% | – |
| Q3 2019 | $3,499,000 | -60.7% | 4,028,000 | -59.9% | 0.00% | -100.0% |
| Q2 2019 | $8,913,000 | -4.6% | 10,050,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $9,338,000 | +18.1% | 10,050,000 | +6.1% | 0.00% | 0.0% |
| Q4 2018 | $7,907,000 | +44.3% | 9,470,000 | +61.3% | 0.00% | 0.0% |
| Q3 2018 | $5,481,000 | -39.8% | 5,870,000 | -30.7% | 0.00% | 0.0% |
| Q2 2018 | $9,106,000 | +101.6% | 8,470,000 | +117.2% | 0.00% | 0.0% |
| Q1 2018 | $4,517,000 | – | 3,900,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |